AU2001262340A1 - A method of treatment of parkinson's disease with a protein extractable from mammalian organs - Google Patents

A method of treatment of parkinson's disease with a protein extractable from mammalian organs

Info

Publication number
AU2001262340A1
AU2001262340A1 AU2001262340A AU6234001A AU2001262340A1 AU 2001262340 A1 AU2001262340 A1 AU 2001262340A1 AU 2001262340 A AU2001262340 A AU 2001262340A AU 6234001 A AU6234001 A AU 6234001A AU 2001262340 A1 AU2001262340 A1 AU 2001262340A1
Authority
AU
Australia
Prior art keywords
parkinson
disease
treatment
mammalian organs
protein extractable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262340A
Inventor
Alberto Panerai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rakepoll Holding BV
Original Assignee
Rakepoll Holding BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding BV filed Critical Rakepoll Holding BV
Publication of AU2001262340A1 publication Critical patent/AU2001262340A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001262340A 2000-06-08 2001-06-04 A method of treatment of parkinson's disease with a protein extractable from mammalian organs Abandoned AU2001262340A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21003200P 2000-06-08 2000-06-08
US60/210,032 2000-06-08
PCT/EP2001/006337 WO2001093894A2 (en) 2000-06-08 2001-06-04 A method of treatment of parkinson's disease with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
AU2001262340A1 true AU2001262340A1 (en) 2001-12-17

Family

ID=22781327

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262340A Abandoned AU2001262340A1 (en) 2000-06-08 2001-06-04 A method of treatment of parkinson's disease with a protein extractable from mammalian organs

Country Status (7)

Country Link
US (1) US20030162704A1 (en)
EP (1) EP1286685A2 (en)
JP (1) JP2003535141A (en)
AU (1) AU2001262340A1 (en)
CA (1) CA2411430A1 (en)
MX (1) MXPA02012092A (en)
WO (1) WO2001093894A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
IT1290828B1 (en) * 1997-03-25 1998-12-11 Zetesis Spa USE OF EXTRACTABLE PROTEINS FROM ANIMAL ORGANS FOR THE PREPARATION OF MEDICATIONS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS

Also Published As

Publication number Publication date
US20030162704A1 (en) 2003-08-28
JP2003535141A (en) 2003-11-25
WO2001093894A2 (en) 2001-12-13
CA2411430A1 (en) 2001-12-13
EP1286685A2 (en) 2003-03-05
WO2001093894A3 (en) 2002-10-31
MXPA02012092A (en) 2004-08-19

Similar Documents

Publication Publication Date Title
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU1407399A (en) Treatment for alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
AU2865000A (en) Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
AU2002319615A1 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002363825A1 (en) Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
AU2002246490A1 (en) Method of treating parkinson's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2001264950A1 (en) Methods of screening for parkinson's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2001273661A1 (en) Methods of screening for alzheimer's disease
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
AU2003248660A1 (en) Treatment of vascular dysfunction and alzheimer's disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU2001279643A1 (en) A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
AU2002303957A1 (en) Method of treating alzheimer's disease with se-containing peptide
AU2001262340A1 (en) A method of treatment of parkinson's disease with a protein extractable from mammalian organs
AU1931895A (en) Treatment of graft-versus-host disease
AU2001278436A1 (en) A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs